Login / Signup

Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.

Tomas KalincikSifat SharminIzanne RoosJennifer MasseyIan SuttonBarbara WithersMark S FreedmanHarold AtkinsEva KrasulovaEva Kubala HavrdovaMarek TrnenyTomas KozakJoachim BurmanRichard MacdonellØivind TorkildsenLars BøAnne Kristine LehmannBasil SharrackJohn Snowden
Published in: Journal of neurology, neurosurgery, and psychiatry (2024)
This study does not support the use of AHSCT to control disability in progressive MS with advanced disability and low relapse activity.
Keyphrases
  • multiple sclerosis
  • stem cell transplantation
  • high dose
  • white matter
  • randomized controlled trial
  • systematic review
  • bone marrow
  • stem cells
  • low dose
  • free survival
  • mesenchymal stem cells
  • mass spectrometry